$MYSZ
My Size, Inc.

2015 Q3 Form 10-Q Financial Statement

#000114420415065802 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q4 2014 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $364.0K $270.0K $118.0K
YoY Change 208.47% 800.0% -268.57%
% of Gross Profit
Research & Development $112.0K -$40.00K $128.0K
YoY Change -12.5%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $476.0K $230.0K $246.0K
YoY Change 93.5% 666.67% -451.43%
Operating Profit -$476.0K -$246.0K
YoY Change 93.5%
Interest Expense -$1.150M -$10.00K -$10.00K
YoY Change 11400.0% 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0%
Pretax Income -$1.630M -$240.0K -$80.00K
YoY Change 1937.5% 71.43% -233.33%
Income Tax
% Of Pretax Income
Net Earnings -$1.614M -$240.0K -$287.0K
YoY Change 462.37% 500.0% -578.33%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.67 -$0.39 -$0.09
COMMON SHARES
Basic Shares Outstanding 15.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.895M $645.0K $970.0K
YoY Change 198.45%
Cash & Equivalents $1.629M $645.0K $967.0K
Short-Term Investments $1.266M
Other Short-Term Assets $1.030M
YoY Change
Inventory
Prepaid Expenses
Receivables $120.0K $110.0K $50.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.048M $688.0K $1.020M
YoY Change 296.86% 2193.33% 5000.0%
LONG-TERM ASSETS
Property, Plant & Equipment $39.00K $24.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $39.00K $91.00K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.048M $688.0K $1.020M
Total Long-Term Assets $39.00K $91.00K $0.00
Total Assets $4.087M $779.0K $1.020M
YoY Change 300.69% 2496.67% 5000.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $139.0K $186.0K $140.0K
YoY Change -0.71% -62.04% -68.18%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.050M $70.00K $70.00K
YoY Change 4257.14% -41.67% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.713M $301.0K $250.0K
YoY Change 2585.2% -67.28% -67.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.713M $301.0K $250.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.720M $300.0K $250.0K
YoY Change 2588.0% -67.39% -67.11%
SHAREHOLDERS EQUITY
Retained Earnings -$6.744M -$3.873M
YoY Change
Common Stock $15.00K $15.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.626M $478.0K $767.0K
YoY Change
Total Liabilities & Shareholders Equity $4.087M $779.0K $1.020M
YoY Change 300.69% 2496.67% 5000.0%

Cashflow Statement

Concept 2015 Q3 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$1.614M -$240.0K -$287.0K
YoY Change 462.37% 500.0% -578.33%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$290.0K -$200.0K -$260.0K
YoY Change 11.54% 100.0%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $30.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K -$30.00K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.380M -100.0K 1.280M
YoY Change 7.81% -211.11%
NET CHANGE
Cash From Operating Activities -290.0K -200.0K -260.0K
Cash From Investing Activities -10.00K -30.00K 0.000
Cash From Financing Activities 1.380M -100.0K 1.280M
Net Change In Cash 1.080M -330.0K 1.020M
YoY Change 5.88% 3200.0%
FREE CASH FLOW
Cash From Operating Activities -$290.0K -$200.0K -$260.0K
Capital Expenditures $10.00K $30.00K $0.00
Free Cash Flow -$300.0K -$230.0K -$260.0K
YoY Change 15.38% 130.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1629000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
645000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
120000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
4048000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
688000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000 USD
CY2015Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
67000 USD
CY2015Q3 us-gaap Assets
Assets
4087000 USD
CY2014Q4 us-gaap Assets
Assets
779000 USD
CY2015Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3043000 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
72000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
139000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
186000 USD
CY2015Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
56000 USD
CY2014Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
6000 USD
CY2015Q3 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
1483000 USD
CY2014Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
0 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6713000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
301000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4800000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4455000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6744000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3873000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-697000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-119000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-2626000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
478000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4087000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
779000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
217000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
128000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
128000 USD
us-gaap Marketing Expense
MarketingExpense
577000 USD
us-gaap Marketing Expense
MarketingExpense
0 USD
CY2015Q3 us-gaap Marketing Expense
MarketingExpense
195000 USD
CY2014Q3 us-gaap Marketing Expense
MarketingExpense
0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
551000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
304000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
169000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
118000 USD
us-gaap Operating Expenses
OperatingExpenses
1345000 USD
us-gaap Operating Expenses
OperatingExpenses
432000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
476000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
246000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1345000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-432000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-476000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-246000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1526000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
5000 USD
CY2015Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1138000 USD
CY2014Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-41000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
209000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-2871000 USD
us-gaap Net Income Loss
NetIncomeLoss
-218000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1614000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-287000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
22000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
25000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
40000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-15000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3449000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-193000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2174000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-302000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
345000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-889000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
767000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1499000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
96000 USD
mysz Adjustment To Additional Paid In Capital Waiver Of Related Parties Debt
AdjustmentToAdditionalPaidInCapitalWaiverOfRelatedPartiesDebt
253000 USD
us-gaap Depreciation
Depreciation
5000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
-289000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
345000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-10000 USD
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-47000 USD
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-75000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-80000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
29000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-913000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-621000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
50000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
mysz Purchase Of Property And Equipment
PurchaseOfPropertyAndEquipment
21000 USD
mysz Purchase Of Property And Equipment
PurchaseOfPropertyAndEquipment
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1602000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1937000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1602000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-19000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-18000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
984000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
963000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
967000 USD
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.0833 pure
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15313793 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15313793 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15313793 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15313793 shares
CY2014Q1 mysz Percentage Of Operating Profit
PercentageOfOperatingProfit
0.18 pure
CY2014Q1 mysz Royalty Agreement Period
RoyaltyAgreementPeriod
P7Y
CY2014 us-gaap Net Income Loss
NetIncomeLoss
468000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
733000 USD
CY2013 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
317000 USD
CY2014Q1 mysz Purchasing Venture Agreement Terms
PurchasingVentureAgreementTerms
As part of the agreement, the Seller received an option to buy back the Venture, for consideration which will reflect the market fair value at that time, on the occurrence of the following events: a) If a motion has been filed to liquidate the Company; b) If 7 years after signing the agreement, the Companys total accumulated revenues, direct or indirect, from the Venture or the commercialization of the patent will be lower than 3.6 million NIS.
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 56.7pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 56.7pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="76"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 28.35pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="38"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">a.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Use of estimates:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
345000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 56.7pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="76"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 28.35pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="38"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">n.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Concentrations of credit risk:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Cash and cash equivalents are invested in major banks in Israel. Such deposits in Israel may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company's investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0in 0in 0pt 56.7pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">The Company and its subsidiaries have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q3 mysz Put Option
PutOption
1033000 USD
CY2014Q4 mysz Put Option
PutOption
0 USD
CY2015Q3 us-gaap Marketable Securities
MarketableSecurities
1266000 USD
CY2014Q4 us-gaap Marketable Securities
MarketableSecurities
USD
CY2015Q3 mysz Warrants Current
WarrantsCurrent
1992000 USD
CY2014Q4 mysz Warrants Current
WarrantsCurrent
37000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
600000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
600000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15313798 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11210263 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15313798 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12013552 shares
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1937000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
mysz Marketable Securities Acquired With Convertible Debt
MarketableSecuritiesAcquiredWithConvertibleDebt
2120000 USD
mysz Marketable Securities Acquired With Convertible Debt
MarketableSecuritiesAcquiredWithConvertibleDebt
0 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1525000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
600000 USD
CY2015Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1266000 USD
CY2015Q1 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
200000000 ILS
CY2015Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
258325000 ILS
CY2015Q1 us-gaap Loss Contingency Damages Sought
LossContingencyDamagesSought
addition of interest of 10% per annum effective from May 20, 2012 through the debt's actual maturity date

Files In Submission

Name View Source Status
0001144204-15-065802-index-headers.html Edgar Link pending
0001144204-15-065802-index.html Edgar Link pending
0001144204-15-065802.txt Edgar Link pending
0001144204-15-065802-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mysz-20150930.xml Edgar Link completed
mysz-20150930.xsd Edgar Link pending
mysz-20150930_cal.xml Edgar Link unprocessable
mysz-20150930_def.xml Edgar Link unprocessable
mysz-20150930_lab.xml Edgar Link unprocessable
mysz-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v424507_10q.htm Edgar Link pending
v424507_ex31-1.htm Edgar Link pending
v424507_ex31-2.htm Edgar Link pending
v424507_ex32-1.htm Edgar Link pending
v424507_ex32-2.htm Edgar Link pending